β¨ Medicines Consent Notices
NEW ZEALAND GAZETTE, No. 86 β 29 SEPTEMBER 2016
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Quetiapine multichem
Quetiapine fumarate 115.13mg equivalent to quetiapine 100mg
Film coated tablet
Multichem NZ Limited
Cipla Limited, Verna, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Quetiapine multichem
Quetiapine fumarate 172.695mg equivalent to quetiapine 150mg
Film coated tablet
Multichem NZ Limited
Cipla Limited, Verna, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Quetiapine multichem
Quetiapine fumarate 230.26mg equivalent to quetiapine 200mg
Film coated tablet
Multichem NZ Limited
Cipla Limited, Verna, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Quetiapine multichem
Quetiapine fumarate 345.39mg equivalent to quetiapine 300mg
Film coated tablet
Multichem NZ Limited
Cipla Limited, Verna, India
Dated this 22nd day of September 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go5486
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Slow Lopresor
Metoprolol tartrate 200mg
Modified release tablet
Novartis New Zealand Limited
Novartis Farma SpA, Torre Annunziata, Italy
Novartis Saglik ve Gida Urunlei Sanayi ve Ticaret AS, Istanbul, Turkey
Dated this 22nd day of September 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go5487
Renewal of Provisional Consent to the Distribution of a Medicine
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Alcaine
Proxymetacaine hydrochloride 5mg/mL
Eye drops, solution
Pharmaco (NZ) Limited
SA Alcon Couvreur NV, Puurs, Belgium
Note: This renewed consent is valid for two years from 2 October 2016.
38
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare22 September 2016
Medicines Act, New Medicines, Quetiapine, Consent
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare22 September 2016
Medicines Act, New Medicine, Metoprolol tartrate, Consent
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
π₯ Renewal of Provisional Consent to the Distribution of a Medicine
π₯ Health & Social Welfare22 September 2016
Medicines Act, Provisional Consent, Proxymetacaine hydrochloride, Renewal
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2016, No 86